SCHEMBL5607987

SCHEMBL5607987

CCOCCN(CCOCC)C(=O)c1sc(NC(=O)O)nc1C

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
CRHR1 P34998 4/20 0.49
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.45
NPC1 O15118 3/20 0.44
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
CSNK1D P48730 1/20 0.42
RXFP1 Q9HBX9 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL773077 0.86 ALDH1A1 (0.54) ALDH1A1CRHR1HPGDTSHRNPC1
SCHEMBL4393473 0.70 RXFP1 (0.53) ALDH1A1HPGDTSHRNPC1POLB
SCHEMBL4473418 0.69 RXFP1 (0.70) ALDH1A1HPGDTSHRNPC1SMN1; SMN2
SCHEMBL774683 0.68 LCK (0.52) ALDH1A1CRHR1NPC1POLBSMN1; SMN2
SCHEMBL3726304 0.68 ALDH1A1 (0.53) ALDH1A1CRHR1HPGDTSHR
SCHEMBL6928652 0.66 CRHR1 (1.00) ALDH1A1CRHR1HPGDNPC1KMT2A
SCHEMBL3722761 0.65 SMN1; SMN2 (0.61) ALDH1A1HPGDNPC1SMN1; SMN2MEN1
SCHEMBL3577082 0.64 ALDH1A1 (0.62) ALDH1A1HPGDTSHRNPC1POLB
SCHEMBL8555317 0.64 ALDH1A1 (0.76) ALDH1A1HPGDTSHRNPC1SMN1; SMN2
SCHEMBL16238270 0.63 RAB9A (0.64) ALDH1A1NPC1POLBSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 EP disclosed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 WO disclosed